Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Bictegravir/Emtricitabine/Tenofovir Alafenide Plus Doravirine
- Status
- COMPLETED
- Phase
- PHASE4
Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant
- Status
- COMPLETED
- Phase
- PHASE4
Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
- Status
- COMPLETED
- Phase
- NA
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
- Status
- COMPLETED
- Phase
- N/A
Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting
- Status
- TERMINATED
- Phase
- PHASE3
Explorations Into the Mechanism for INSTI-associated Weight Gain: a Focus on Energy Balance
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy
- Status
- WITHDRAWN
- Phase
- PHASE3
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy
- Status
- WITHDRAWN
- Phase
- PHASE3
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406
- Status
- COMPLETED
- Phase
- PHASE1
Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Remdesivir in Participants Below 18 Years Old With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
DHFS for Medication Adherence Support During Hospital Admissions for Person Living With HIV
- Status
- COMPLETED
- Phase
- PHASE4
A Test and Treat Strategy in New HIV Diagnosis.
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
- Status
- COMPLETED
- Phase
- PHASE3